Culture
Judges find ‘no merit’ in most of preliminary objections from penny stock crash masterminds
THE Court of Appeal has found no merit in three of the five preliminary objections raised by John Soh’s and Quah Su-Ling’s counsels on Monday (Mar 3). Soh and...
Vincent Tong becomes CEO of iFast’s Singapore arm
He replaces Lim Chung Chun, who will continue to be group CEO and chairman of iFast CorpDIGITAL banking and investment platform iFast Corp appointed Vincent Tong as the chief...
BYD launches share sale to raise up to US$5.2 billion, term sheet shows
CHINESE electric vehicle maker BYD has launched a sale of its Hong Kong shares to raise up to US$5.2 billion via an accelerated book-building, according to a deal term...
Analysts upgrade First Resources to ‘buy’ on FY2024 earnings beat; counter jumps 9%
MAYBANK and RHB on Monday (Mar 3) upgraded palm oil player First Resources to “buy”, on the back of stronger-than-expected profits logged for FY2024 ended December. Analysts also pointed...
Garuda set to replace head of low cost unit in push for recovery
INDONESIAN flag carrier Garuda Indonesia is planning to replace the head of its low cost unit, Citilink Indonesia, in an effort to boost profitability and recover from the fallout...
Australian pension funds have dry powder to deploy to real estate
TWO of Australia’s biggest pension funds that together count A$520 billion (S$436 billion) in assets under management (AUM) said they have money they can pump into real estate investments.“Do...
Bank of England may need to pause rate cuts, ex-officials warn
BANK of England (BOE) governor Andrew Bailey thinks a renewed bout of inflation is nothing to worry about. Former policymakers are less convinced and say the central bank may...
Xiaomi debuts pricey 15 Ultra smartphone with advanced cameras
XIAOMI introduced a new flagship handset priced at 1,499 euros (S$2,108) in a bid to push further into the premium market traditionally dominated by Apple.The Xiaomi 15 Ultra comes...
Blackstone buys Japan drug trial firm, adding to private equity health deals
BLACKSTONE is buying a company that helps drugmakers run clinical trials in Japan, adding to growing interest from private equity firms in the health needs of the nation’s ageing...